Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE

Filgotinib 200 mg (FIL200) is an approved treatment for adults with moderately to severely active ulcerative colitis (UC). To report integrated safety data from the phase 2b/3 SELECTION study (NCT02914522) and its ongoing long-term extension study SELECTIONLTE (NCT02914535). Safety outcomes were ana...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alimentary pharmacology & therapeutics 2023-11, Vol.58 (9), p.874-887
Hauptverfasser:	Schreiber, Stefan, Rogler, Gerhard, Watanabe, Mamoru, Vermeire, Séverine, Maaser, Christian, Danese, Silvio, Faes, Margaux, Van Hoek, Paul, Hsieh, Jeremy, Moerch, Ulrik, Zhou, Yan, de Haas, Angela, Rudolph, Christine, Oortwijn, Alessandra, Loftus, Jr, Edward V
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological Products - therapeutic use Cardiovascular diseases Colitis, Ulcerative - drug therapy Herpes zoster Humans Inflammatory bowel disease Patients Placebos Pyridines - therapeutic use Risk factors Safety Thromboembolism Triazoles - therapeutic use Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!